E. J. Vollaard
-
- Antibiotic Use and Resistance 3
-
- Nosocomial Infections in ICU 5
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 8
- Infectious Diseases top 5%
- Clostridium difficile and Clostridium perfringens research 4
- Clinical Biochemistry top 5%
-
- Neutropenia and Cancer Infections 4
-
- Mycobacterium research and diagnosis 3
- Urinary Tract Infections Management 3
-
- Inflammatory mediators and NSAID effects 3
- Co-authors
- H. A. L. ClasenerH. K. F. van SaeneJan FestenHenk J.J. van LierMartin MetzRoelof van DalenH. J. M. JoostenR. van Dalen
- Cited by
- Applied Microbiology and BiotechnologyCritical Care and Intensive Care MedicineMolecular Medicine
- Journals
- Clinical Infectious Diseases (1 paper)CHEST Journal (1 paper)Antimicrobial Agents and Chemotherapy (2 papers)
- Partner nations
- Netherlands
In The Last Decade
E. J. Vollaard
27 papers receiving 778 citations
Peers
Comparison fields: 5 of 92
- Applied Microbiology and Biotechnology 77
- Critical Care and Intensive Care Medicine 173
- Molecular Medicine 127
- Infectious Diseases 271
- Clinical Biochemistry 87
Countries citing papers authored by E. J. Vollaard
This map shows the geographic impact of E. J. Vollaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. J. Vollaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. J. Vollaard more than expected).
Fields of papers citing papers by E. J. Vollaard
This network shows the impact of papers produced by E. J. Vollaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. J. Vollaard. The network helps show where E. J. Vollaard may publish in the future.
Co-authorship network
The 23 scholars most cited alongside E. J. Vollaard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 15 | |
| 2 | Coxibs versus gastroprotection. Prevention of NSAID-induced gastro-intestinal toxicity | 2001 | 0 |
| 3 | 1992 | 12 | |
| 4 | 1992 | 9 | |
| 5 | 1992 | 29 | |
| 6 | 1992 | 6 | |
| 7 | The concept of colonization resistance: a study of the influence of antimicrobial agents on the aerobic flora of the bowel | 1991 | 2 |
| 8 | 1991 | 74 | |
| 9 | 1991 | 2 | |
| 10 | 1990 | 19 | |
| 11 | 1990 | 13 | |
| 12 | 1990 | 25 | |
| 13 | 1990 | 16 | |
| 14 | 1989 | 17 | |
| 15 | 1988 | 2 | |
| 16 | 1988 | 9 | |
| 17 | 1987 | 12 | |
| 18 | 1987 | 70 | |
| 19 | 1987 | 7 | |
| 20 | 1979 | 1 |
About E. J. Vollaard
E. J. Vollaard is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Critical Care and Intensive Care Medicine, having authored 29 papers that have together received 810 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (8 papers), Nosocomial Infections in ICU (5 papers), Neutropenia and Cancer Infections (4 papers), Clostridium difficile and Clostridium perfringens research (4 papers), Antibiotic Use and Resistance (3 papers), Mycobacterium research and diagnosis (3 papers), Urinary Tract Infections Management (3 papers) and Inflammatory mediators and NSAID effects (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (77 citations), Critical Care and Intensive Care Medicine (173 citations) and Molecular Medicine (127 citations). E. J. Vollaard has collaborated with scholars based in Netherlands. Frequent co-authors include H. A. L. Clasener, H. K. F. van Saene, Jan Festen, Henk J.J. van Lier, Martin Metz, Roelof van Dalen, H. J. M. Joosten, R. van Dalen, D.J.W. van Kraaij and A.C. Beynen. Their work appears in journals such as Clinical Infectious Diseases, CHEST Journal and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.